ArticleCancer medicine2024

Frontline evaluation: Atezolizumab-bevacizumab versus lenvatinib for BCLC stage B hepatocellular carcinoma exceeding the up-to-seven criteria.

Masamichi Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.